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We consider how data from scientific research should be used
for decision making in health services. Whether a hand hy-
giene intervention to reduce risk of nosocomial infection
should be widely adopted is the case study. Improving hand
hygiene has been described as the most important measure
to prevent nosocomial infection.1 Transmission of microor-
ganisms is reduced, and fewer infections arise, which leads
to a reduction in mortality2 and cost savings.3 Implementing
a hand hygiene program is itself costly, so the extra investment
should be tested for cost-effectiveness.4,5
The first part of our commentary is about cost-effectiveness
models and how they inform decision making for health ser-
vices. The second part is about how data on the effectiveness
of hand hygiene programs arising from scientific studies are
used, and 2 points are made: the threshold for statistical
inference of .05 used to judge effectiveness studies is not
important for decision making,6,7 and potentially valuable evi-
dence about effectiveness might be excluded by decision mak-
ers because it is deemed low quality.8 The ideas put forward
will help researchers and health services decision makers to
appraise scientific evidence in a more powerful way.
cost-effectiveness models
These provide signals about how to allocate a fixed budget
between competing health programs when the objective is to
maximize health benefits.9 If a new program increases costs
and reduces health benefits, it should never be adopted. If it
saves costs and increases health benefits, it should always be
adopted. It may, however, provide an opportunity to trade
higher costs for additional health benefits. These 3 situations
are shown in Figure 1. Whether a trade is worthwhile depends
on how much decision makers are willing to pay for 1 unit
of health benefit, such as a quality-adjusted life-year
(QALY).10 The dashed line in Figure 1 shows that this value
is $50,000 per QALY, and this means that the dashed line is
a threshold for a good decision.11 Imagine a hand hygiene
program that increases costs by $800,000 and generates an
extra 16 QALYs. The cost per QALY gained is $50,000
($800,000 divided by 16) and so the result, relative to existing
practice at the origin, lies exactly on the threshold for good
decision making. If the new hand hygiene program costs more
than $50,000 per QALY, then it would be above the dashed
line, and adoption would be a bad decision. If it costs less,
it would be below the line, and adoption would be a good
decision.
Information Required for Cost-Effectiveness Models
Multiple pieces of information are combined to make predic-
tions of cost-effectiveness,12 and we use hypothetical data
shown in Table 1 to make our points clear. The first 4 param-
eters are used to estimate the increase in costs from a new
hand hygiene program to cover 20,000 patients. The program
implementation cost is $3,000,000 and is made by multiplying
60 by $40,000 and then adding $400,000 and another $200,000.
The next 5 parameters are used to predict cost savings that
would result from adopting the program. There would be 800
fewer infections among the 20,000 patients if hand hygiene
were adopted (8% of 20,000 minus 4% of 20,000). Five bed-
days are saved for each of the 800 patients, which, when valued
at $500 together with the $250 treatment costs per case, gives
a total economic savings of $2,200,000. The change to total
cost is positive by $800,000, because we deduct $2,200,000 from
$3,000,000. Predicting the change to health benefits requires
information for the last 2 parameters in Table 1; 0.1% of the
800 patients enjoy an extra 20 years of life, meaning that the
health benefits are 16 QALYs. If 0.8 people seems like a strange
outcome, then remember that this is a modeling study.
Using the Information
Table 1 shows single values for 11 separate parameters used
to estimate the model outcomes of $800,000 and 16 QALYs.
We are not certain of these parameter values, because pop-
ulations are variable. For the “treatment costs of infection”
parameter, the mean value is $250, but the cost of treating
some patients will be cheaper than the cost of treating others.
The statistical distribution of this parameter is shown in Fig-
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figure 1. A summary of decision making outcomes. QALY, quality-adjusted life-year.
table 1. Information Needed to Estimate the Increase in Costs from
Adoption of a Hand Hygiene Program
How information is used, parameter Parameter value
To estimate cost increases
No. of extra staff 60
Wages per staff member $40,000
Cost of all extra hand cleaning product $400,000
Costs of coordination group $200,000
To estimate cost savings
Risk of infection with existing practice, % 8
Risk of infection with hand hygiene intervention, % 4
Extra days’ stay due to infection 5
Value of a bed-day $500
Treatment costs of infection $250
To estimate health benefits
Extra death risk for those infected, % 0.1
Years of life lost because of early death 20
ure 2 and reveals that a small number of patients cost less
than $150 or more than $400 to treat. All 11 parameters in
the decision model have values distributed with uncertainty,
and these uncertainties must be included if the model is to
be useful.13
Evaluating the model is done by randomly picking a value
from the distribution of each parameter and making a single
prediction of cost-effectiveness. Imagine the first random pick
from the parameter distributions arose from one end of the
distributions. A very short prolongation of stay or very low
value for program effectiveness, for example, would steer the
cost-effectiveness estimate above the threshold line and show
decision makers that adoption is not cost-effective; another
random pick with different values might steer the estimate
below the line, and the opposite conclusion would be drawn.
After 1,000 random picks have been made, it is the proportion
of results below the threshold line that show the probability
that the decision is cost-effective. This is called probabilistic
sensitivity analysis.14 If the proportion of results below the
threshold is greater than 500 (50%) of 1,000, then a rational
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figure 2. Statistical distribution for a model parameter.
table 2. Four Versions of the Effectiveness Parameters with Reducing Variances, by Study Size
Variable Small Medium Large Very large
No. of participants 50 400 800 1,600
No. of infections
Hand hygiene group 1/24 10/190 20/380 40/760
Control group 2/23 16/184 32/368 64/736
Risk
Hand hygiene 0.04 0.05 0.05 0.05
No hand hygiene 0.08 0.08 0.08 0.08
Relative risk (95% confidence interval) 0.50 (0.05–5.17) 0.63 (0.29–1.34) 0.63 (0.36–1.07) 0.63a (0.43–0.92)
a Statistically significant at the 5% level.
and risk-neutral decision maker would maximize the chance
of economic benefit by adopting the program.15
how the data on hand hygiene
effectiveness are used
This section is about the intervention effectiveness data for
hand hygiene. We use hypothetical values of 8% and 4% in
the decision model. Many studies of hand hygiene interven-
tions have been published and included in reviews. A Coch-
rane Collaboration review by Gould et al16 is thorough and
up to date. The authors assess strategies to improve hand
hygiene compliance; they extracted data from 4 studies17-20
and excluded data from 129 studies. The authors judged the
excluded designs to be insufficiently robust to attribute any
observed changes to the intervention, with many words de-
voted to criticizing the quality of the studies, in line with
Cochrane recommendations. That some results were not sta-
tistically significant at the .05 level was also a feature of the
review, and the importance of this judgment is considered
next.
Statistical Significance and Decision Making
We suggest that the threshold for statistical inference of .05
used to judge effectiveness is not important for decision mak-
ing.7 Imagine that the model parameters that describe the
effectiveness of the hand hygiene intervention in Table 1 arose
from a small trial whose 50 participants were assigned equally
in a randomized trial. The relative risk is 0.5, and the 95%
confidence interval is 0.05–5.17 (Table 2).
Many in the scientific community would disregard this
evidence, because the level of confidence in the conclusion
is a long way from the 95% level used to judge whether the
observed difference in the outcome is real, or statistically
significant. However, when the result from this small trial of
50 individuals is used in the cost-effectiveness model, we see
in Figure 3 that 570 of the 1,000 resamples lie below the
dashed threshold line, and so there is a 57% chance that
adoption of the hand hygiene program is a good decision.
Substituting estimates from the medium, large, and very large
trials increases confidence in the decision to 71%, 74%, and
82%, respectively. A statistically significant result for the ef-
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figure 3. Decision making outcomes with uncertainty; data from 4 similar trials of different sizes are used.
fectiveness parameter is not required for the optimal decision
to be made.21 A decision maker might adopt the intervention
on the basis of a 57% level of certainty, because the probability
favors this, but the very small number of infections seen in
the small trial may cause risk aversion. It might be that de-
cision makers are comfortable at the 74% level of decision
certainty provided by the medium-size trial of 400 patients.
Investing in the large trials with 800 or 1,600 participants
might not help decision makers much but would incur large
data collection costs in an erroneous quest for a result that
meets the arbitrary .05 criterion for statistical significance.
Valuable Evidence about Effectiveness Might Be Excluded
Gould et al16 excluded 129 of the 133 studies because of their
lack of rigor or relevance. Rigor summarizes issues that give
rise to internal biases, and relevance summarizes issues that
may threaten external validity. The strict quality control in
the study by Gould et al16 means that the estimates included
may be less biased, but few data are available; thus, the var-
iance around the parameter estimate could be very high, and
the uncertainty in the decision could be large. An extreme
example would be a situation in which all evidence is rejected
as being of poor quality, thereby implying that nothing is
known. This rather shortsighted conclusion ignores the fact
that decision makers are still required to make a choice as
to whether to adopt an intervention and will still use evidence
to guide their decision, albeit with lower confidence. The
opposite situation would be one in which most studies are
included to guide decision making; variance and uncertainty
among parameters would be reduced, but the model estimate
might be strongly biased. Ideally, estimates are adjusted to
reduce sources of bias, thereby allowing more information to
be included, which reduces variance and decision uncertainty.
Turner et al22 describe a simple method that allows for
internal and external biases in evidence synthesis. The result
is a bias-adjusted meta-analysis that emerges from methods
that can be implemented routinely. Indeed, the authors sug-
gest that, for each study, the bias elicitation process lasted 1
hour plus a minimum of 1 hour of preparation, with the
completion of the bias checklist requiring at least 3 hours.
This seems a good use of time for researchers and policy
makers seeking to clarify the value of infection control pro-
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grams, because repeating the study to get a less biased result
would be much more costly. Sutton et al23 and Ades et al24
have written specifically about including observational data
for decision making. The inclusion of more evidence, ad-
justing its quality if required, will reduce uncertainty in de-
cision making and may reduce the need for expensive new
data collection.
conclusions
We have considered how data arising from scientific research
should be used for decision making in health services. In the
cost-effectiveness modeling, it was assumed that decision
makers are both risk neutral and rational, meaning that they
should simply choose the option that maximizes expected
benefits. In reality, decision makers are often risk averse,25
have a preference for the status quo,26 and are susceptible to
a range of other judgmental and decision biases.27 Changing
healthcare policy is no easy task, and often the evidence that
motivates the decision maker to “take the plunge” needs to
be overwhelming.28
We conclude that decision makers may be uncomfortable
adopting an intervention in which the outcomes are uncer-
tain, particularly when this stems from highly influential pa-
rameters, such as the estimates of effectiveness for interven-
tions.29 This does not undermine our key message that less
than perfect information can be used to make better deci-
sions. Scientific studies contribute valuable information to
decision making, but such studies alone cannot provide an-
swers as to how scarce healthcare resources should be used.
A broader framework is required that uses many data, often
drawn from different sources in a cost-effectiveness modeling
study.
The authors of the Cochrane review16 that motivated us to
write this article struggled with their conclusions. They failed
to find evidence to support the effectiveness of hand hygiene
interventions, but then recommended that hand hygiene pro-
grams be implemented and promoted. The recommendation
was not based on the narrow evidence that they assembled
for effectiveness. Instead, it implicitly incorporates a much
wider range of considerations, including the cost-effectiveness
and acceptability of hand hygiene programs. This is a com-
mon scenario, and we sympathize with the authors.
In this commentary, we have illustrated that an arbitrary
threshold of .05 for statistical significance is not relevant for
decision making and that studies of variable quality can con-
tribute useful information to decisions. We call for high-
quality modeling studies in the field of infection control in-
terventions and recommend appropriate use of existing data
to help decision makers increase health benefits from scarce
resources.
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